Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$0.21 - $0.35 $10,400 - $17,334
49,526 Added 26.86%
233,931 $53,000
Q4 2022

Feb 14, 2023

SELL
$0.22 - $8.4 $42,813 - $1.63 Million
-194,606 Reduced 51.35%
184,405 $44,000
Q3 2022

Nov 14, 2022

BUY
$0.41 - $8.8 $52,088 - $1.12 Million
127,046 Added 50.42%
379,011 $147,000
Q2 2022

Aug 15, 2022

SELL
$0.42 - $0.65 $208,939 - $323,358
-497,475 Reduced 66.38%
251,965 $152,000
Q1 2022

May 16, 2022

BUY
$0.54 - $2.74 $354,303 - $1.8 Million
656,117 Added 703.06%
749,440 $452,000
Q4 2021

Feb 14, 2022

BUY
$2.33 - $3.37 $130,978 - $189,441
56,214 Added 151.48%
93,323 $249,000
Q3 2021

Nov 15, 2021

BUY
$2.52 - $2.99 $25,588 - $30,360
10,154 Added 37.67%
37,109 $102,000
Q2 2021

Aug 16, 2021

SELL
$2.6 - $3.65 $1.68 Million - $2.36 Million
-646,733 Reduced 96.0%
26,955 $77,000
Q1 2021

May 17, 2021

BUY
$2.73 - $4.5 $641,629 - $1.06 Million
235,029 Added 53.58%
673,688 $2.31 Million
Q4 2020

Feb 16, 2021

BUY
$2.6 - $3.32 $113,815 - $145,333
43,775 Added 11.09%
438,659 $1.16 Million
Q3 2020

Nov 16, 2020

SELL
$2.46 - $4.27 $29,726 - $51,598
-12,084 Reduced 2.97%
394,884 $1.23 Million
Q2 2020

Aug 14, 2020

BUY
$1.45 - $4.3 $521,592 - $1.55 Million
359,719 Added 761.33%
406,968 $1.68 Million
Q1 2020

May 15, 2020

BUY
$0.75 - $2.55 $107 - $364
143 Added 0.3%
47,249 $76,000
Q4 2019

Feb 14, 2020

SELL
$1.65 - $2.48 $13,328 - $20,033
-8,078 Reduced 14.64%
47,106 $117,000
Q3 2019

Nov 14, 2019

SELL
$1.48 - $2.52 $109,998 - $187,293
-74,323 Reduced 57.39%
55,184 $93,000
Q2 2019

Aug 14, 2019

SELL
$2.45 - $3.32 $51,467 - $69,743
-21,007 Reduced 13.96%
129,507 $324,000
Q1 2019

May 15, 2019

SELL
$2.52 - $3.24 $286,667 - $368,572
-113,757 Reduced 43.05%
150,514 $462,000
Q4 2018

Feb 14, 2019

BUY
$1.92 - $4.1 $126,044 - $269,156
65,648 Added 33.05%
264,271 $698,000
Q3 2018

Nov 14, 2018

BUY
$3.39 - $4.61 $673,331 - $915,652
198,623 New
198,623 $856,000
Q2 2018

Aug 14, 2018

BUY
$1.89 - $4.95 $173,862 - $455,355
91,991 New
91,991 $362,000
Q4 2017

Feb 14, 2018

SELL
$1.91 - $2.83 $167,283 - $247,859
-87,583 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$2.44 - $2.91 $213,702 - $254,866
87,583
87,583 $235,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0

About MEI Pharma, Inc.


  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $385M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.